These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15363824)
1. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Sáez GT; Tormos C; Giner V; Chaves J; Lozano JV; Iradi A; Redón J Am J Hypertens; 2004 Sep; 17(9):809-16. PubMed ID: 15363824 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in hypertension: association with antihypertensive treatment. Khanna HD; Sinha MK; Khanna S; Tandon R Indian J Physiol Pharmacol; 2008; 52(3):283-7. PubMed ID: 19552060 [TBL] [Abstract][Full Text] [Related]
3. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052 [TBL] [Abstract][Full Text] [Related]
5. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370 [TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. White WB; Lacourciere Y; Davidai G Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889 [TBL] [Abstract][Full Text] [Related]
7. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R; J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371 [TBL] [Abstract][Full Text] [Related]
8. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591 [TBL] [Abstract][Full Text] [Related]
10. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension. White WB; Davidai G; Schumacher H J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698 [TBL] [Abstract][Full Text] [Related]
11. [Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?]. MMW Fortschr Med; 2003 Jun; 145(23):59. PubMed ID: 12854231 [No Abstract] [Full Text] [Related]
12. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M; Richter WO; Schwandt P; Holzgreve H Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension. Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. Palmieri V; Devereux RB Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398 [TBL] [Abstract][Full Text] [Related]
16. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
17. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?]. Chazova IE Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969 [No Abstract] [Full Text] [Related]
18. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension. Neutel JM; Littlejohn TW; Chrysant SG; Singh A; Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883 [TBL] [Abstract][Full Text] [Related]
19. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial. Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]